Quince Therapeutics name change follows Orphai merger
Dow Jones Newswires says Quince Therapeutics’ name change follows completion of its previously announced merger with Orphai Therapeutics and a concurrent private placement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Quince Therapeutics relaunches as IRulya Therapeutics
The company said it changed its name to IRulya Therapeutics effective Oct. 9 and will trade on Nasdaq under ticker IRLA from Oct. 12. It also announced new leadership appointments and said its cash balance should fund operations through the end of 2028.